Tag: Leqembi containing lecanemab-irmb for treatment of early stages of Alzheimer’s disease

New drug Leqembi containing lecanemab-irmb for treatment of Alzheimer’s disease approved by US FDA under accelerated approval pathway. There are very few treatments available for treatment of Alzheimer’s disease, people affected with Alzheimer’s disease are not able to do daily tasks, and there is a risk of forgetting the way back to home when they go…